HomeAIMI • OTCMKTS
add
AIM ImmunoTech Inc
Nakaraang pagsara
$0.068
Sakop ng araw
$0.051 - $0.087
Sakop ng taon
$0.025 - $0.36
Market cap
4.93M USD
Average na Volume
408.61K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 45.00K | -30.77% |
Gastos sa pagpapatakbo | 5.89M | -58.08% |
Net na kita | -5.97M | 52.55% |
Net profit margin | -13.26K | 31.46% |
Kita sa bawat share | -0.10 | 64.56% |
EBITDA | -5.79M | 58.48% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 3.98M | -69.57% |
Kabuuang asset | 8.61M | -55.59% |
Kabuuang sagutin | 9.93M | 8.56% |
Kabuuang equity | -1.32M | — |
Natitirang share | 72.29M | — |
Presyo para makapag-book | -3.40 | — |
Return on assets | -131.89% | — |
Return on capital | -369.07% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -5.97M | 52.55% |
Cash mula sa mga operasyon | -3.96M | 59.47% |
Cash mula sa pag-invest | 3.70M | 1,830.84% |
Cash mula sa financing | 1.04M | 605.44% |
Net change in cash | 786.00K | 108.00% |
Malayang cash flow | -3.65M | 40.05% |
Tungkol
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Itinatag
1966
Headquarters
Website
Mga Empleyado
22
